Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Jiwei Li, Jin Li, Meizuo Zhong, Hui Zhou & Baohua Yu. (2021) The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study. Cancer Management and Research 13, pages 1541-1549.
Read now
Read now
Jin Li, Yajun Li, Ruolan Zeng, Jingguan Lin, Meizuo Zhong, Xianling Liu, Yizi He, Junqiao He, Zhou Ouyang, Lijun Huang, Ling Xiao & Hui Zhou. (2020) Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis. Therapeutics and Clinical Risk Management 16, pages 1151-1163.
Read now
Read now
Yi Chen, Luting Luo, Xiaoyun Zheng, Haiying Fu, Xiaozhu Yang, Wanling Huang, Lushan Chen, Zhihong Zheng, Jing Zheng, Ting Yang, Tingbo Liu & Jianda Hu. (2020) Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis. Leukemia & Lymphoma 61:14, pages 3306-3318.
Read now
Read now
Liqiang Wei, Jingwen Wang, Jin Ye, Lei Yang, Jia Cong, Xin Li, Yiping Wu, Xueying Cui, Jing Ding, Na Yao & Jing Yang. (2020) Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study. Leukemia & Lymphoma 61:2, pages 337-343.
Read now
Read now
Christopher P. Fox, Ariane Boumendil, Norbert Schmitz, Herve Finel, Jian J. Luan, Gülsan Sucak, Didier Blaise, Jürgen Finke, Karl-Heinz Pflüger, Hendrik Veelken, Norbert -Claude Gorin, Xavier Poiré, Arnold Ganser, Peter Dreger & Anna Sureda. (2015) High-dose therapy and autologous stem cell transplantation for extra-nodal NK/T lymphoma in patients from the Western hemisphere: a study from the European Society for Blood and Marrow Transplantation. Leukemia & Lymphoma 56:12, pages 3295-3300.
Read now
Read now
Wook Youn Kim, Soo Jeong Nam, Sehui Kim, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim & Yoon Kyung Jeon. (2015) Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities. Leukemia & Lymphoma 56:6, pages 1778-1786.
Read now
Read now
Hua Wang, Zhi-Jun Wuxiao, Jiayu Zhu, Zhihui Wang, Ke-Feng Wang, Su Li, Xiaoqin Chen, Yue Lu & Zhong-Jun Xia. (2015) Comparison of gemcitabine, oxaliplatin and L-asparaginase and etoposide, vincristine, doxorubicin, cyclophosphamide and prednisone as first-line chemotherapy in patients with stage IE to IIE extranodal natural killer/T-cell lymphoma: a multicenter retrospective study. Leukemia & Lymphoma 56:4, pages 971-977.
Read now
Read now
Li Jiang, Shao-Jun Li, Yue-Ming Jiang, Jian-Xiong Long, Ren-Sheng Wang, Jing Su & Yong Zhang. (2014) The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis. Leukemia & Lymphoma 55:5, pages 1038-1048.
Read now
Read now
Huiqiang Huang, Zexiao Lin, Xubin Lin, Qingqing Cai, Zhongjun Xia & Wenqi Jiang. (2011) Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience. Leukemia & Lymphoma 52:6, pages 1041-1048.
Read now
Read now
Holbrook Kohrt, Mark Lee & Ranjana Advani. (2010) Risk stratification in extranodal natural killer/T-cell lymphoma. Expert Review of Anticancer Therapy 10:9, pages 1395-1405.
Read now
Read now
Holbrook Kohrt & Ranjana Advani. (2009) Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leukemia & Lymphoma 50:11, pages 1773-1784.
Read now
Read now
Seok Jin Kim, Byung Soo Kim, Chul Won Choi, Hee Yun Seo, Hye Ryoung Seol, Hwa Jung Sung, In Sun Kim, Chul Yong Kim, Kwang Yoon Jung & Jun Suk Kim. (2006) Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract. Leukemia & Lymphoma 47:7, pages 1265-1273.
Read now
Read now
Keun-wook Lee, Tak Yun, Dong-wan Kim, Seock-ah Im, Tae-you Kim, Sung-soo Yoon, Dae Seog Heo, Yung-jue Bang, Seonyang Park, Byoung Kook Kim & Noe Kyeong Kim. (2006) First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leukemia & Lymphoma 47:7, pages 1274-1282.
Read now
Read now
Articles from other publishers (49)
Peng Sun, Yajun Li, Cong Li, Kexing Ren, Yu Wang, Hang Yang, Wenqi Jiang, Liqun Zou, Haiyan Yang, Hui Zhou & Zhi‐Ming Li. (2023)
A phase
II
study of sintilimab, anlotinib, and pegaspargase sandwiched with radiotherapy as first‐line therapy in patients with newly diagnosed, stage
I–II
extranodal natural‐killer/T‐cell lymphoma
. American Journal of Hematology 98:7, pages 1043-1051.
Crossref
Crossref
Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao & Yanyan Liu. (2023) Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology 14.
Crossref
Crossref
Siti Sarah Mohd Ramli, Salina Husain & Yin Ping Wong. (2021) Extranodal NK/T cell lymphoma, nasal type: a rare diagnosis with common nasal presentation. BMJ Case Reports 14:6, pages e236436.
Crossref
Crossref
Chong Wei, Xinxin Cao, Wei Zhang, Yan Zhang, Wei Wang, Lu Zhang, Chen Yang, Jun Feng, Huacong Cai, Miao Chen, Yueying Mao & Daobin Zhou. (2020) Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study. Annals of Hematology 99:12, pages 2801-2809.
Crossref
Crossref
Christopher P Fox, Monica Civallero, Young-Hyeh Ko, Martina Manni, Tetiana Skrypets, Stefano Pileri, Seok Jin Kim, Maria Elena Cabrera, Andrei R Shustov, Carlos S Chiattone, Steven M Horwitz, Ivan Dlouhy, Michele Spina, Felicitas Hitz, Silvia Montoto, Arnon Nagler, Virginia Martinez, Carmino A De Souza, Ruben Fernandez-Alvarez, Veronika Ballova, Raul Gabús, Giorgio Inghirami, Massimo Federico & Won Seog Kim. (2020) Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. The Lancet Haematology 7:4, pages e284-e294.
Crossref
Crossref
Fang Zhu, Tao Liu, Huaxiong Pan, Yin Xiao, Qiuhui Li, Xinxiu Liu, Wangbing Chen, Gang Wu & Liling Zhang. (2020) Long-term outcomes of upfront concurrent chemoradiotherapy followed by P-GDP regimen in newly diagnosed early stage extranodal nasal-type NK/T cell lymphoma. Medicine 99:33, pages e21705.
Crossref
Crossref
Larry Hadley & Kokila Lakhoo. 2020. Pediatric Surgery. Pediatric Surgery
1103
1109
.
Ze-Long Liu, Xi-Wen Bi, Xue-Wen Zhang, De-Xin Lei, Pan-Pan Liu, Hang Yang, Yan Gao, Yuan-Xue Jiang, Wen-Qi Jiang & Yi Xia. (2019) Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell Lymphoma of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience. Cancer Research and Treatment 51:4, pages 1557-1567.
Crossref
Crossref
S.H. Lim, J.Y. Hong, S.T. Lim, H. Hong, J. Arnoud, W. Zhao, D.H. Yoon, T. Tang, J. Cho, S. Park, Y.H. Ko, S.J. Kim, C. Suh, T. Lin & W.S. Kim. (2017) Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease. Annals of Oncology 28:9, pages 2199-2205.
Crossref
Crossref
Yi-Yang Li, Ling-Ling Feng, Shao-Qing Niu, Han-Yu Wang, Lu-Lu Zhang, Liang Wang, Zhong-Jun Xia, Hui-Qiang Huang, Yun-Fei Xia, Yu-Jing Zhang & Xi-Cheng Wang. (2016) Radiotherapy improves survival in early stage extranodal natural killer/T cell lymphoma patients receiving asparaginase-based chemotherapy. Oncotarget 8:7, pages 11480-11488.
Crossref
Crossref
Shao-Qing Niu, Yong Yang, Yi-Yang Li, Ge Wen, Liang Wang, Zhi-Ming Li, Han-Yu Wang, Lu-Lu Zhang, Yun-Fei Xia & Yu-Jing Zhang. (2016) Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma. Chinese Journal of Cancer 35:1.
Crossref
Crossref
Xin Li, Yingying Cui, Zhenchang Sun, Lei Zhang, Ling Li, Xinhua Wang, Jingjing Wu, Xiaorui Fu, Wang Ma, Xudong Zhang, Yu Chang, Feifei Nan, Wencai Li, Liping Su, Jinghua Wang, Hongwei Xue & Mingzhi Zhang. (2016) DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China. Clinical Cancer Research 22:21, pages 5223-5228.
Crossref
Crossref
Xiao-mei Jing, Zhi-hui Zhang, Ping Wu, Shi-chuan Zhang, Yuan-rong Ren, Zhu-juan Xiong, Wen Wei, Lei Luo & Li Li. (2016) Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma. Leukemia Research 47, pages 26-31.
Crossref
Crossref
Jing-hua Wang, Hua Wang, Yan-jun Wang, Zhong-jun Xia, Hui-qiang Huang, Wen-qi Jiang & Yue Lu. (2016) Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma. Oncotarget 7:23, pages 35412-35422.
Crossref
Crossref
SHANSHAN BU, FANGFANG YUAN, XUDONG WEI, QINGSONG YIN, YUFU LI, RUIHUA MI, HAIPING YANG, HONGYI LI, SHOUBEI GE, YANYAN LIU & YONGPING SONG. (2016) L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphoma. Experimental and Therapeutic Medicine 11:6, pages 2437-2445.
Crossref
Crossref
Man Nie, Xi-wen Bi, Wen-wen Zhang, Peng Sun, Yi Xia, Pan-pan Liu, Hui-qiang Huang, Wen-qi Jiang & Zhi-ming Li. (2016) Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma. Scientific Reports 6:1.
Crossref
Crossref
Jing-jing Wang, Mei Dong, Xiao-hui He, Ye-xiong Li, Wei-hu Wang, Peng Liu, Jian-liang Yang, Lin Gui, Chang-gong Zhang, Sheng Yang, Sheng-yu Zhou & Yuan-kai Shi. (2016) GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Medicine 95:6, pages e2787.
Crossref
Crossref
Tae Hyung KimJin Seok KimYang-Gun SuhJaeho ChoWoo-Ick YangChang-Ok Suh. (2016) The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma. Yonsei Medical Journal 57:4, pages 846.
Crossref
Crossref
Miso Kim, Tae Min Kim, Ki Hwan Kim, Bhumsuk Keam, Se-Hoon Lee, Dong-Wan Kim, Jong Seok Lee, Yoon Kyung Jeon, Chul Woo Kim & Dae Seog Heo. (2014) Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus l-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL). Annals of Hematology 94:3, pages 437-444.
Crossref
Crossref
F.-G. Riet, C.-H. Canova, J. Gabarre, S. Ben Hassine, L. Kamsu Kom, J.-J. Mazeron & L. Feuvret. (2014) Radiothérapie des lymphomes NK/T localisés aux fosses nasales. Cancer/Radiothérapie 18:2, pages 147-153.
Crossref
Crossref
Won Seog Kim, Seok Jin Kim & Young Hyeh Ko. 2014. Rare Lymphomas. Rare Lymphomas
121
131
.
Jayoung Lee, Seok-Goo Cho, Su-Mi Chung, Mi Ryeong Ryu, Sung Hwan Kim, Hong-Seok Jang & Byung-Ock Choi. (2012) Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL). Annals of Hematology 92:3, pages 333-343.
Crossref
Crossref
Liang Wang, Zhi‐hui Wang, Xiao‐qin Chen, Ya‐jun Li, Ke‐feng Wang, Yun‐fei Xia & Zhong‐jun Xia. (2012) First‐line combination of gemcitabine, oxaliplatin, and L‐asparaginase (GELOX) followed by involved‐field radiation therapy for patients with stage IE/IIE extranodal natural killer/T‐cell lymphoma. Cancer 119:2, pages 348-355.
Crossref
Crossref
Martine BagotT. Petrella & S. Dalle. 2013. Les lymphomes cutanés. Les lymphomes cutanés
133
137
.
Ming Jiang, Hong Zhang, Yu Jiang, Qunpei Yang, Li Xie, Weiping Liu, Wenyan Zhang, Xiaohui Ji, Ping Li, Nianyong Chen, Sha Zhao, Feng Wang & Liqun Zou. (2011)
Phase 2 trial of “Sandwich”
L
‐asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma
. Cancer 118:13, pages 3294-3301.
Crossref
Crossref
Seok Jin KimYong ParkByung Soo KimInsun KimYoung Hye KoWon Seog Kim. (2012) Extranodal natural killer/T-cell lymphoma with long-term survival and repeated relapses: does it indicate the presence of indolent subtype?. The Korean Journal of Hematology 47:3, pages 202.
Crossref
Crossref
Christopher P Fox, Claire Shannon-Lowe & Martin Rowe. (2011) Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae 2:1.
Crossref
Crossref
Abeer N. AbouYabis, Pareen J. Shenoy, Rajni Sinha, Christopher R. Flowers & Mary Jo Lechowicz. (2011) A Systematic Review and Meta-Analysis of Front-line Anthracycline-Based Chemotherapy Regimens for Peripheral T-Cell Lymphoma. ISRN Hematology 2011, pages 1-14.
Crossref
Crossref
Z.Y. Wang, Y.X. Li, H. Wang, W.H. Wang, J. Jin, Y.P. Liu, Y.W. Song, S.L. Wang, X.F. Liu & Z.H. Yu. (2011) Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma. Annals of Oncology 22:2, pages 390-396.
Crossref
Crossref
Hyun Jin LeeSang-Wook LeeCheolwon SuhJooryung HuhSang Min YoonYoung Seok KimSu San KimJong Hoon KimEun Kyung ChoiSeung Do Ahn. (2011) Treatment outcome of nasal natural killer/T-cell lymphoma. Radiation Oncology Journal 29:3, pages 174.
Crossref
Crossref
Seok Jin Kim & Won Seog Kim. (2010) Treatment of localized extranodal NK/T cell lymphoma, nasal type. International Journal of Hematology 92:5, pages 690-696.
Crossref
Crossref
Christopher P. FoxTracey A. HaighGraham S. TaylorHeather M. LongSteven P. LeeClaire Shannon-LoweSimon O'ConnorCatherine M. Bollard, Javeed Iqbal, Wing C. Chan, Alan B. RickinsonAndrew I. BellMartin Rowe. (2010) A novel latent membrane 2 transcript expressed in Epstein-Barr virus–positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy. Blood 116:19, pages 3695-3704.
Crossref
Crossref
Seok Jin KimKihyun KimByung Soo KimChul Yong KimCheolwon SuhJooryung HuhSang-Wook LeeJin Seok KimJaeho ChoGyeong-Won LeeKi Mun KangHyeon Seok EomHong Ryull PyoYong Chan AhnYoung Hyeh KoWon Seog Kim. (2009) Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study. Journal of Clinical Oncology 27:35, pages 6027-6032.
Crossref
Crossref
Tae Min Kim & Dae Seog Heo. (2009) Extranodal NK / T‐cell lymphoma, nasal type: New staging system and treatment strategies. Cancer Science 100:12, pages 2242-2248.
Crossref
Crossref
Y-L. Choi, J-H. Park, J-H. Namkung, J-H. Lee, J-M. Yang, E-S. Lee, D-Y. Lee, K-T. Jang & Y-H. Ko. (2009) Extranodal NK / T-cell lymphoma with cutaneous involvement: ‘nasal’ vs. ‘nasal-type’ subgroups- a retrospective study of 18 patients. British Journal of Dermatology 160:2, pages 333-337.
Crossref
Crossref
B.-S. Kim, D.-W. Kim, S.-A. Im, C.W. Kim, T.-Y. Kim, S.-S. Yoon, D.S. Heo, Y.-J. Bang, S. Park, B.K. Kim & N.K. Kim. (2009) Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Annals of Oncology 20:1, pages 121-128.
Crossref
Crossref
Y. Li. 2010. Management of Rare Adult Tumours. Management of Rare Adult Tumours
73
85
.
Ye Guo, Jiade J. Lu, Xuejun Ma, Biyun Wang, Xiaonan Hong, Xiaoqiu Li & Jin Li. (2008) Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: Elucidating the significance of systemic chemotherapy. Oral Oncology 44:1, pages 23-30.
Crossref
Crossref
Mei-juan Huang, Yu Jiang, Wei-ping Liu, Zhi-ping Li, Mei Li, Lin Zhou, Yong Xu, Chun-hua Yu, Qiu Li, Feng Peng, Ji-Yan Liu, Feng Luo & You Lu. (2008) Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive Tract. International Journal of Radiation Oncology*Biology*Physics 70:1, pages 166-174.
Crossref
Crossref
Yexiong Li & Jiade J. Lu. 2008. Radiation Oncology. Radiation Oncology
445
460
.
Im I. Na, Hye J. Kang, Yeon H. Park, Seung-Sook Lee, Hyung J. Yoo, Du H. Choe, Baek-Yeol Ryoo & Sung H. Yang. (2007) Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia. European Journal of Haematology 79:1, pages 1-7.
Crossref
Crossref
Céline BossardKarim BelhadjFelix ReyesNadine Martin-GarciaFrançoise BergerJean Alain KummerJosette BrièreAnne-Catherine BaglinStéphane ChezeJacques BosqVincent RibragChristian Gisselbrecht, Nicolas Mounier & Philippe Gaulard. (2006) Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 109:5, pages 2183-2189.
Crossref
Crossref
L. Pagano, A. Gallamini, G. Trapè, L. Fianchi, D. Mattei, G. Todeschini, A. Spadea, S. Cinieri, E. Iannitto, M. Martelli, A. Nosari, E. Di Bona, M.E. Tosti, M.C. Petti, P. Falcucci, M. Montanaro, A. Pulsoni, L.M. Larocca & G. Leone. (2006) NK/T-cell lymphomas ‘nasal type’: an Italian multicentric retrospective survey. Annals of Oncology 17:5, pages 794-800.
Crossref
Crossref
Weiben Yong, Wen Zheng, Jun Zhu, Yuntao Zhang, Yan Wei, Xiaopei Wang, Ningjing Lin, Yan Xie, Be Xu & Jiyou Li. (2006) Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect ofL-asparaginase based regimen, and prognostic factors. Hematological Oncology 24:1, pages 28-32.
Crossref
Crossref
Ye-Xiong LiBo YaoJing JinWei-Hu WangYue-Ping LiuYong-Wen SongShu-Lian WangXin-Fan LiuLi-Qiang ZhouXiao-Hui HeNing LuZi-Hao Yu. (2006) Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma. Journal of Clinical Oncology 24:1, pages 181-189.
Crossref
Crossref
Raymond Liang. 2006. The Lymphomas. The Lymphomas
451
455
.
Neal Luther, Jeffrey P. Greenfield, Amy Chadburn & Theodore H. Schwartz. (2005) Intracranial Nasal Natural Killer/T-cell Lymphoma: Immunopathologically-Confirmed Case and Review of Literature. Journal of Neuro-Oncology 75:2, pages 185-188.
Crossref
Crossref
Jeeyun Lee, Yeon Hee Park, Won Seog Kim, Seung-Sook Lee, Baek-Yeol Ryoo, Sung Hyun Yang, Keon Woo Park, Jung Hoon Kang, Joon Oh Park, Se Hoon Lee, Kihyun Kim, Chul Won Jung, Young Suk Park, Young-Hyuck Im, Won Ki Kang, Mark H. Lee, Young H. Ko, Yong Chan Ahn & Keunchil Park. (2005) Extranodal nasal type NK/T-cell Lymphoma: Elucidating clinical prognostic factors for risk-based stratification of therapy. European Journal of Cancer 41:10, pages 1402-1408.
Crossref
Crossref
J Lee, W S Kim, Y H Park, S H Park, K W Park, J H Kang, S S Lee, S I Lee, S-H Lee, K Kim, C W Jung, Y C Ahn, Y H Ko & K Park. (2005) Nasal-type NK/T cell lymphoma: clinical features and treatment outcome. British Journal of Cancer 92:7, pages 1226-1230.
Crossref
Crossref